肝性脑病的中西医结合诊疗进展与展望

王宪波; 时克

doi:10.3969/j.issn.1001-5256.2022.09.004

肝性脑病的中西医结合诊疗进展与展望

DOI: 10.3969/j.issn.1001-5256.2022.09.004

王宪波^, ,,
时克

首都医科大学附属北京地坛医院中西医结合中心，北京 100015

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：时克负责撰写论文及文献收集；王宪波负责拟定写作思路，指导撰写文章并最后定稿。

详细信息

通信作者:
王宪波，wangxianbo638@163.com

计量
- 文章访问数: 766
- HTML全文浏览量: 131
- PDF下载量: 108
- 被引次数: 0
出版历程
- 收稿日期: 2022-06-16
- 录用日期: 2022-07-20
- 出版日期: 2022-09-20

Integrated traditional Chinese and Western medicine diagnosis and treatment of hepatic encephalopathy: Advances and perspectives

Xianbo WANG^{,
,},
Ke SHI

Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China

More Information

Corresponding author: WANG Xianbo, wangxianbo638@163.com(ORCID: 0000-0002-3593-5741)

摘要

摘要: 肝性脑病是肝硬化和门静脉高压最常见的并发症。在诊断方面需明确诱因、疾病分期，根据神经心理学测试或临床症状、体征进行识别。肝性脑病的治疗强调去除诱因、降氨治疗、合理恰当的营养支持，中西医结合治疗具有一定优势和特色。本文论述了肝性脑病的中西医结合诊疗进展，旨在指导临床实践，选择合理的治疗方案。
- 肝性脑病 /
- 诊断 /
- 中西医结合疗法
Abstract: Hepatic encephalopathy is the most common complication of liver cirrhosis and portal hypertension, and a confirmed diagnosis requires the clarification of predisposing factors and disease stage based on neuropsychological tests or clinical symptoms and signs. The treatment of hepatic encephalopathy emphasizes the elimination of predisposing factors, ammonia-lowering treatment, and reasonable and appropriate nutrition support, and integrated traditional Chinese and Western medicine therapy has certain advantages and characteristics in treatment. This article discusses the advances in the integrated traditional Chinese and Western medicine diagnosis and treatment of hepatic encephalopathy, so as to guide clinical practice and select reasonable treatment regimens.
- Hepatic Encephalopathy /
- Diagnosis /
- TCM WM Therapy

HTML全文

参考文献(37)

[1]	VILSTRUP H, AMODIO P, BAJAJ J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver[J]. Hepatology, 2014, 60(2): 715-735. DOI: 10.1002/hep.27210.
[2]	Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of hepatic encephalopathy in cirrhosis[J]. J Clin Hepatol, 2018, 34(10): 2076-2089. DOI: 10.3969/j.issn.1001-5256.2018.10.007. 中华医学会肝病学分会. 肝硬化肝性脑病诊疗指南[J]. 临床肝胆病杂志, 2018, 34(10): 2076-2089. DOI: 10.3969/j.issn.1001-5256.2018.10.007.
[3]	LU L, LU BJ, AN YT, et al. Clinical progress of diagnosis and treatment for hepatic encephalopathy in western and traditional Chinese medicine[J]. J Liaoning Univ Tradit Chin Med, 2019, 21(6): 127-131. DOI: 10.13194/j.issn.1673-842x.2019.06.034. 陆璐, 鲁冰洁, 安永潼, 等. 肝性脑病中西医诊疗进展[J]. 辽宁中医药大学学报, 2019, 21(6): 127-131. DOI: 10.13194/j.issn.1673-842x.2019.06.034.
[4]	HUANG YY, ZHANG Q, SHI K, et al. Progress of Chinese medicine and pharmacy in treating hepatic encephalopathy[J]. Chin J Integr Trad West Med, 2020, 40(5): 638-640. DOI: 10.7661/j.cjim.20200328.316. 黄云义, 张群, 时克, 等. 中医药治疗肝性脑病的研究进展[J]. 中国中西医结合杂志, 2020, 40(5): 638-640. DOI: 10.7661/j.cjim.20200328.316.
[5]	YANNY B, WINTERS A, BOUTROS S, et al. Hepatic encephalopathy challenges, burden, and diagnostic and therapeutic approach[J]. Clin Liver Dis, 2019, 23(4): 607-623. DOI: 10.1016/j.cld.2019.07.001.
[6]	SHARMA P, SHARMA BC, PURI V, et al. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy[J]. J Hepatol, 2007, 47(1): 67-73. DOI: 10.1016/j.jhep.2007.02.022.
[7]	FONIO P, DISCALZI A, CALANDRI M, et al. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification[J]. Radiol Med, 2017, 122(9): 713-721. DOI: 10.1007/s11547-017-0770-6.
[8]	BASS NM, MULLEN KD, SANYAL A, et al. Rifaximin treatment in hepatic encephalopathy[J]. N Engl J Med, 2010, 362(12): 1071-1081. DOI: 10.1056/NEJMoa0907893.
[9]	WIJDICKS EF. Hepatic encephalopathy[J]. N Engl J Med, 2016, 375(17): 1660-1670. DOI: 10.1056/NEJMra1600561.
[10]	ROSE CF, AMODIO P, BAJAJ JS, et al. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy[J]. J Hepatol, 2020, 73(6): 1526-1547. DOI: 10.1016/j.jhep.2020.07.013.
[11]	JANVE VS, HERNANDEZ CC, VERDIER KM, et al. Epileptic encephalopathy de novo GABRB mutations impair γ-aminobutyric acid type A receptor function[J]. Ann Neurol, 2016, 79(5): 806-825. DOI: 10.1002/ana.24631.
[12]	KOBTAN AA, EL-KALLA FS, SOLIMAN HH, et al. Higher grades and repeated recurrence of hepatic encephalopathy may be related to high serum manganese levels[J]. Biol Trace Elem Res, 2016, 169(2): 153-158. DOI: 10.1007/s12011-015-0405-5.
[13]	BAJAJ JS, LAURIDSEN M, TAPPER EB, et al. Important unresolved questions in the management of hepatic encephalopathy: An ISHEN Consensus[J]. Am J Gastroenterol, 2020, 115(7): 989-1002. DOI: 10.14309/ajg.0000000000000603.
[14]	JIANG TT, LIU XL, JIANG YY, et al. Minimal hepatic encephalopathy and Biejia-Ruangan are associated with first hospital readmission in nonalcoholic cirrhosis patients[J]. Evid Based Complement Alternat Med, 2021, 2021: 6652858. DOI: 10.1155/2021/6652858.
[15]	DI COLA S, NARDELLI S, RIDOLA L, et al. Ammonia and the muscle: an emerging point of view on hepatic encephalopathy[J]. J Clin Med, 2022, 11(3): 611. DOI: 10.3390/jcm11030611.
[16]	TOPAN MM, SPOREA I, DǍNILǍ M, et al. Impact of sarcopenia on survival and clinical outcomes in patients with liver cirrhosis[J]. Front Nutr, 2021, 8: 766451. DOI: 10.3389/fnut.2021.766451.
[17]	BUCHARD B, BOIRIE Y, CASSAGNES L, et al. Assessment of malnutrition, sarcopenia and frailty in patients with cirrhosis: which tools should we use in clinical practice?[J]. Nutrients, 2020, 12(1): 186. DOI: 10.3390/nu12010186.
[18]	MAHARSHI S, SHARMA BC, SACHDEVA S, et al. Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial[J]. Clin Gastroenterol Hepatol, 2016, 14(3): 454-460. DOI: 10.1016/j.cgh.2015.09.028.
[19]	REUTER B, SHAW J, HANSON J, et al. Nutritional assessment in inpatients with cirrhosis can be improved after training and is associated with lower readmissions[J]. Liver Transpl, 2019, 25(12): 1790-1799. DOI: 10.1002/lt.25602.
[20]	LI JY, XIN XY, YANG HS. Experience of QIAN Ying in treating minimal hepatic encephalopathy[J]. China J Tradit Chin Med Pharma, 2021, 36(7): 4022-4024. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202107060.htm 李晶滢, 辛喜艳, 杨华升. 钱英辨治轻微型肝性脑病经验[J]. 中华中医药杂志, 2021, 36(7): 4022-4024. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202107060.htm
[21]	MAO DW, QIU H, WEI AL. Research on syndrome and treatment of TCM in hepatic encephalopathy[J]. Tianjin J Tradit Chin Med, 2007, 24(3): 225-227. DOI: 10.3969/j.issn.1672-1519.2007.03.017. 毛德文, 邱华, 韦艾凌. 肝性脑病的中医证治研究[J]. 天津中医药, 2007, 24(3): 225-227. DOI: 10.3969/j.issn.1672-1519.2007.03.017.
[22]	SU WT, LU BJ. Clinical experience of Professor Lu Bingjiu in treatment of hepatic encephalopathy in liver cirrhosis[J]. Yunnan J Tradit Chin Med Mater Med, 2019, 40(5): 12-14. DOI: 10.3969/j.issn.1007-2349.2019.05.004. 苏文涛, 卢秉久. 卢秉久教授治疗肝硬化肝性脑病的临床经验[J]. 云南中医中药杂志, 2019, 40(5): 12-14. DOI: 10.3969/j.issn.1007-2349.2019.05.004.
[23]	ZHANG XR, ZHAO WX. Experience summary of famous traditional Chinese medicine physician professor Zhao Wenxia in treating hepatic encephalopathy[J]. Guangming J Chin Med, 2020, 35(13): 1979-1982. DOI: 10.3969/j.issn.1003-8914.2020.13.012. 张小瑞, 赵文霞. 全国名老中医赵文霞教授诊治肝性脑病的经验总结[J]. 光明中医, 2020, 35(13): 1979-1982. DOI: 10.3969/j.issn.1003-8914.2020.13.012.
[24]	WAN LF. Clinical experience of chief physician Shao Ming treating hepatic encephalopathy[J]. J Chengdu Univ Tradit Chin Med, 2010, 33(3): 38, 44. https://www.cnki.com.cn/Article/CJFDTOTAL-CDZY201003015.htm 万凌峰. 邵铭主任医师辨证论治肝性脑病经验[J]. 成都中医药大学学报, 2010, 33(3): 38, 44. https://www.cnki.com.cn/Article/CJFDTOTAL-CDZY201003015.htm
[25]	LI F, LAI JF, FU YY, et al. Dr. Shi Weiqun's experience in treating hepatic encephalopathy with "Xinkaikujiang Method"[J]. Zhejiang J Integr Tradit Chin West Med, 2019, 29(11): 875-876. DOI: 10.3969/j.issn.1005-4561.2019.11.001. 李峰, 来杰锋, 傅燕燕, 等. 施维群运用"辛开苦降法"治疗肝性脑病经验[J]. 浙江中西医结合杂志, 2019, 29(11): 875-876. DOI: 10.3969/j.issn.1005-4561.2019.11.001.
[26]	JIANG TT, YANG ZY, JIANG YY, et al. Risk factors and characteristics of TCM syndromes of mild hepatic encephalopathy[J]. Beijing J Tradit Chin Med, 2019, 38(3): 211-215. DOI: 10.16025/j.1674-1307.2019.03.004. 姜婷婷, 杨志云, 江宇泳, 等. 轻微型肝性脑病的发病危险因素及中医证型分布规律[J]. 北京中医药, 2019, 38(3): 211-215. DOI: 10.16025/j.1674-1307.2019.03.004.
[27]	WANG RB, MA YF, ZHANG W, et al. Modified Dahuang Decoction with high position enema on hepatic coma[J]. J Emerg Tradit Chin Med, 2014, 23(6): 1075-1076. DOI: 10.3969/j.issn.1004-745X.2014.06.027. 王融冰, 马剡芳, 张伟, 等. 复方大黄煎剂高位灌肠治疗肝昏迷[J]. 中国中医急症, 2014, 23(6): 1075-1076. DOI: 10.3969/j.issn.1004-745X.2014.06.027.
[28]	FAN MX, ZHANG ZD, MIAO HJ. Clinical observation on treatment of hepatic encephalopathy with Angong Niuhuang pill and Xingnaojing injection[J]. Chin Arch Tradit Chin Med, 2020, 38(2): 237-240. DOI: 10.13193/j.issn.1673-7717.2020.02.059. 范铭兴, 张曾娣, 缪红军. 安宫牛黄丸联合醒脑静注射液治疗肝性脑病临床观察[J]. 中华中医药学刊, 2020, 38(2): 237-240. DOI: 10.13193/j.issn.1673-7717.2020.02.059.
[29]	ZHOU W. Clinical observation on treatment of liver cirrhosis complicated with hepatic encephalopathy by integrative Chinese and Western medicine[J]. Guide China Med, 2020, 18(13): 190-191. https://www.cnki.com.cn/Article/CJFDTOTAL-YYXK202013089.htm 周伟. 中西医结合疗法救治肝硬化合并肝性脑病的临床观察[J]. 中国医药指南, 2020, 18(13): 190-191. https://www.cnki.com.cn/Article/CJFDTOTAL-YYXK202013089.htm
[30]	LIAO BL, ZHU JF, WANG LT, et al. Clinical study on Xinqingkai Decoction in preventing and treating chronic HBV infection-induced liver cirrhosis complicated with mild hepatic encephalopathy[J]. Shanghai J Tradit Chin Med, 2021, 55(2): 63-67. DOI: 10.16305/j.1007-1334.2021.2001101. 廖冰灵, 祝峻峰, 王灵台, 等. 新清开方防治慢性乙型肝炎后肝硬化合并轻微型肝性脑病的临床研究[J]. 上海中医药杂志, 2021, 55(2): 63-67. DOI: 10.16305/j.1007-1334.2021.2001101.
[31]	LU HZ, YU H, GAO X. Clinical study on Chaihu plus Longgu Muli Tang combined with lactulose for minimal hepatic encephalopathy[J]. J New Chin Med, 2020, 52(16): 27-29. DOI: 10.13457/j.cnki.jncm.2020.16.007. 卢红治, 于浩, 高翔. 柴胡加龙骨牡蛎汤联合乳果糖治疗轻微型肝性脑病临床研究[J]. 新中医, 2020, 52(16): 27-29. DOI: 10.13457/j.cnki.jncm.2020.16.007.
[32]	BIAN Q, XIE XK, KOU XN, et al. Clinical observation on Tongfu Jiangzhuo Decoction combined with lactulose in treating hepatic encephalopathy of heat disturbing heart mind type[J]. Shandong J Tradit Chin Med, 2021, 40(6): 577-582. DOI: 10.16295/j.cnki.0257-358x.2021.06.007. 边倩, 解新科, 寇小妮, 等. 通腑降浊汤联合乳果糖治疗热扰心神型肝性脑病临床观察[J]. 山东中医杂志, 2021, 40(6): 577-582. DOI: 10.16295/j.cnki.0257-358x.2021.06.007.
[33]	CUI YY, CHEN PL, CHEN ZY, et al. Meta-analysis of effects of Xingnaojing injection with ornithine aspartate on hepatic encephalopathy[J]. Chin J Integr Tradit West Med Liver Dis, 2021, 31(9): 822-827, 834. DOI: 10.3969/j.issn.1005-0264.2021.09.014. 崔亚运, 陈鹏兰, 陈梓洋, 等. 醒脑静联合门冬氨酸鸟氨酸治疗肝性脑病患者疗效的Meta分析[J]. 中西医结合肝病杂志, 2021, 31(9): 822-827, 834. DOI: 10.3969/j.issn.1005-0264.2021.09.014.
[34]	ZHANG FL, WU JQ, WANG XH, et al. Clinical effect of ornithine aspartate combined with Qingkailing in treatment of hepatic encephalopathy[J]. Mod J Integr Tradit Chin West Med, 2011, 20(1): 54-55. DOI: 10.3969/j.issn.1008-8849.2011.01.032. 张锋利, 吴洁琼, 王小红, 等. 门冬氨酸鸟氨酸联合清开灵治疗肝性脑病疗效观察[J]. 现代中西医结合杂志, 2011, 20(1): 54-55. DOI: 10.3969/j.issn.1008-8849.2011.01.032.
[35]	LI WK, CHEN WY, LIAO NJ, et al. Clinical effect of Angong Niuhuang pills in treatment of stage 2-4 hepatic encephalopathy in liver cirrhosis[J]. The Medical Forum, 2019, 23(7): 937-939. DOI: 10.19435/j.1672-1721.2019.07.029. 李文科, 陈文炎, 廖楠君, 等. 安宫牛黄丸治疗肝硬化肝性脑病(2~4期)的临床疗效观察[J]. 基层医学论坛, 2019, 23(7): 937-939. DOI: 10.19435/j.1672-1721.2019.07.029.
[36]	LI JF, LUO TC, AN ZX. A Meta analysis of treating hepatic encephalopathy with An'gong Niuhuang Wan with western medicine[J]. Clin J Chin Med, 2020, 12(35): 142-145. DOI: 10.3969/j.issn.1674-7860.2020.35.048. 李金芳, 罗天赐, 安祯祥. 安宫牛黄丸联合西药治疗肝性脑病的Meta分析[J]. 中医临床研究, 2020, 12(35): 142-145. DOI: 10.3969/j.issn.1674-7860.2020.35.048.
[37]	ZHANG P, ZHANG B. Clinical study on treatment of minimal hepatic encephalopathy with Shijun Granule[J]. Shanghai J Tradit Chin Med, 2017, 51(1): 57-60. DOI: 10.16305/j.1007-1334.2017.01.017. 张平, 张斌. 石军颗粒治疗轻微型肝性脑病的临床研究[J]. 上海中医药杂志, 2017, 51(1): 57-60. DOI: 10.16305/j.1007-1334.2017.01.017.